Literature DB >> 26515984

Marijuana Legalization: Impact on Physicians and Public Health.

Samuel T Wilkinson1, Stephanie Yarnell1, Rajiv Radhakrishnan1,2,3, Samuel A Ball1,2,4, Deepak Cyril D'Souza1,2,3.   

Abstract

Marijuana is becoming legal in an increasing number of states for both medical and recreational use. Considerable controversy exists regarding the public health impact of these changes. The evidence for the legitimate medical use of marijuana or cannabinoids is limited to a few indications, notably HIV/AIDS cachexia, nausea/vomiting related to chemotherapy, neuropathic pain, and spasticity in multiple sclerosis. Although cannabinoids show therapeutic promise in other areas, robust clinical evidence is still lacking. The relationship between legalization and prevalence is still unknown. Although states where marijuana use is legal have higher rates of use than nonlegal states, these higher rates were generally found even prior to legalization. As states continue to proceed with legalization for both medical and recreational use, certain public health issues have become increasingly relevant, including the effects of acute marijuana intoxication on driving abilities, unintentional ingestion of marijuana products by children, the relationship between marijuana and opioid use, and whether there will be an increase in health problems related to marijuana use, such as dependence/addiction, psychosis, and pulmonary disorders. In light of this rapidly shifting legal landscape, more research is urgently needed to better understand the impact of legalization on public health.

Entities:  

Keywords:  cannabis; legalization; medical marijuana; public health

Mesh:

Substances:

Year:  2015        PMID: 26515984      PMCID: PMC4900958          DOI: 10.1146/annurev-med-050214-013454

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  94 in total

1.  Cannabis use and later life outcomes.

Authors:  David M Fergusson; Joseph M Boden
Journal:  Addiction       Date:  2008-06       Impact factor: 6.526

2.  Marijuana use and car crash injury.

Authors:  Stephanie Blows; Rebecca Q Ivers; Jennie Connor; Shanthi Ameratunga; Mark Woodward; Robyn Norton
Journal:  Addiction       Date:  2005-05       Impact factor: 6.526

3.  Cannabinoid-opioid interaction in chronic pain.

Authors:  D I Abrams; P Couey; S B Shade; M E Kelly; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  2011-11-02       Impact factor: 6.875

4.  Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial.

Authors:  Jonathan S Berman; Catherine Symonds; Rolfe Birch
Journal:  Pain       Date:  2004-12       Impact factor: 6.961

5.  Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19.

Authors:  Rongrong Jiang; Satoshi Yamaori; Yasuka Okamoto; Ikuo Yamamoto; Kazuhito Watanabe
Journal:  Drug Metab Pharmacokinet       Date:  2013-01-15       Impact factor: 3.614

6.  Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).

Authors:  Claudine C Hunault; Tjeert T Mensinga; Koen B E Böcker; C Maarten A Schipper; Maaike Kruidenier; Marianne E C Leenders; Irma de Vries; Jan Meulenbelt
Journal:  Psychopharmacology (Berl)       Date:  2008-12-20       Impact factor: 4.530

7.  Marijuana and driving in real-life situations.

Authors:  H Klonoff
Journal:  Science       Date:  1974-10-25       Impact factor: 47.728

8.  Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

Authors:  J E Beal; R Olson; L Laubenstein; J O Morales; P Bellman; B Yangco; L Lefkowitz; T F Plasse; K V Shepard
Journal:  J Pain Symptom Manage       Date:  1995-02       Impact factor: 3.612

9.  Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.

Authors:  Marta Di Forti; Hannah Sallis; Fabio Allegri; Antonella Trotta; Laura Ferraro; Simona A Stilo; Arianna Marconi; Caterina La Cascia; Tiago Reis Marques; Carmine Pariante; Paola Dazzan; Valeria Mondelli; Alessandra Paparelli; Anna Kolliakou; Diana Prata; Fiona Gaughran; Anthony S David; Craig Morgan; Daniel Stahl; Mizanur Khondoker; James H MacCabe; Robin M Murray
Journal:  Schizophr Bull       Date:  2013-12-17       Impact factor: 9.306

10.  Prognosis of schizophrenia in persons with and without a history of cannabis use.

Authors:  E Manrique-Garcia; S Zammit; C Dalman; T Hemmingsson; S Andreasson; P Allebeck
Journal:  Psychol Med       Date:  2014-09       Impact factor: 7.723

View more
  38 in total

1.  Prevalence and correlates of marijuana use among HIV-seropositive and seronegative men in the Multicenter AIDS Cohort Study (MACS), 1984-2013.

Authors:  Chukwuemeka N Okafor; Robert L Cook; Xinguang Chen; Pamela J Surkan; James T Becker; Steve Shoptaw; Eileen Martin; Michael W Plankey
Journal:  Am J Drug Alcohol Abuse       Date:  2016-11-03       Impact factor: 3.829

2.  Comparison of Parent, Peer, Psychiatric, and Cannabis Use Influences Across Stages of Offspring Alcohol Involvement: Evidence from the COGA Prospective Study.

Authors:  Kathleen K Bucholz; Vivia V McCutcheon; Arpana Agrawal; Danielle M Dick; Victor M Hesselbrock; John R Kramer; Samuel Kuperman; John I Nurnberger; Jessica E Salvatore; Marc A Schuckit; Laura J Bierut; Tatiana M Foroud; Grace Chan; Michie Hesselbrock; Jacquelyn L Meyers; Howard J Edenberg; Bernice Porjesz
Journal:  Alcohol Clin Exp Res       Date:  2017-01-10       Impact factor: 3.455

Review 3.  Medical cannabis for chronic pain: can it make a difference in pain management?

Authors:  Mari Kannan Maharajan; Yu Jing Yong; Hong Yang Yip; Sze Shee Woon; Kar Mon Yeap; Khai Yeng Yap; Shuen Chi Yip; Kai Xian Yap
Journal:  J Anesth       Date:  2019-09-18       Impact factor: 2.078

4.  The emerging public discourse on state legalization of marijuana for recreational use in the US: Analysis of news media coverage, 2010-2014.

Authors:  Emma E McGinty; Hillary Samples; Sachini N Bandara; Brendan Saloner; Marcus A Bachhuber; Colleen L Barry
Journal:  Prev Med       Date:  2016-06-30       Impact factor: 4.018

5.  A 10-year review of cannabis exposure in children under 3-years of age: do we need a more global approach?

Authors:  Isabelle Claudet; Mathilde Le Breton; Camille Bréhin; Nicolas Franchitto
Journal:  Eur J Pediatr       Date:  2017-02-16       Impact factor: 3.183

6.  Association between cannabis laws and opioid prescriptions among privately insured adults in the US.

Authors:  Mukaila A Raji; N Ogechi Abara; Habeeb Salameh; Jordan R Westra; Yong-Fang Kuo
Journal:  Prev Med       Date:  2019-05-21       Impact factor: 4.018

7.  Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain.

Authors:  James A Cranford; J Todd Arnedt; Deirdre A Conroy; Kipling M Bohnert; Carrie Bourque; Frederic C Blow; Mark Ilgen
Journal:  Drug Alcohol Depend       Date:  2017-09-09       Impact factor: 4.492

8.  Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.

Authors:  Gustavo Gonzalez-Cuevas; Remi Martin-Fardon; Tony M Kerr; David G Stouffer; Loren H Parsons; Dana C Hammell; Stan L Banks; Audra L Stinchcomb; Friedbert Weiss
Journal:  Neuropsychopharmacology       Date:  2018-03-22       Impact factor: 7.853

9.  Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men.

Authors:  Chukwuemeka N Okafor; Michael W Plankey; Michael Li; Xinguang Chen; Pamela J Surkan; Steve Shoptaw; Eileen Martin; Ronald Cohen; Ned Sacktor; Robert L Cook
Journal:  Subst Use Misuse       Date:  2019-01-30       Impact factor: 2.164

10.  Co-use of tobacco and marijuana during pregnancy: Pathways to externalizing behavior problems in early childhood.

Authors:  Stephanie A Godleski; Shannon Shisler; Rina D Eiden; Marilyn A Huestis
Journal:  Neurotoxicol Teratol       Date:  2018-08-04       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.